Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects

Clinical trial NCT06054698 · COMPLETED

Trial details

NCT number: NCT06054698
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight or Obesity

Start date: 2023-10-16
Primary completion: 2024-09-09
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.